Key highlights from Marksans Pharma Limited (MARKSANS) Q3 FY23 Earnings Concall Q&A Highlights: [00:08:54] Riddhesh Gandhi from Discovery Capital asked why there
Marksans Pharma Limited Q3 FY23 Earnings Conference Call Insights
Categories
pharmaceuticals
Earnings Summary Of Granules India Limited For Q3 FY23
Granules India Limited (NSE: GRANULES) is a pharmaceutical manufacturing company based in Hyderabad, India. The company was founded in 1984 and has
Marksans Pharma Limited (MARKSANS) Q3 FY23 Earnings Concall Transcript
Marksans Pharma Limited (NSE:MARKSANS) Q3 FY23 Earnings Concall dated Feb. 14, 2023. Corporate Participants: Mark Saldanha -- Managing Director and Chief Executive Officer Jitendra
Biocon ltd.(NSE: BIOCON) Ltd. : Q3 FY23 Results Out; Total Income rise 35% YoY
Biocon Limited (NSE:BIOCON) is an Indian multinational biopharmaceutical company based in Bangalore, India. The company was founded in 1978 by Kiran Mazumdar-Shaw
Brooks Laboratories Ltd.(NSE: BROOKS) Ltd. : Q3 FY23 Results Out; Total Income fell 20% YoY
Brooks Laboratories Limited (NSE: BROOKS) is a pharmaceutical contract research and manufacturing services company based in India. It offers a range of
Themis Medicare Ltd (THEMISMED) Q3 FY23 Earnings Concall Transcript
Themis Medicare Ltd (NSE:THEMISMED) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Sachin D. Patel -- Managing Director and Chief Executive Officer
Ipca Laboratories Limited Q3 FY23; Revenue Increased To ₹1,546 Crore
Ipca Laboratories Limited (NSE: IPCALAB) reported Revenue from Operations for Q3 FY23 of ₹1,546 Crore up from ₹1,430.47 Crore year on year,
Glenmark Pharmaceuticals Limited (GLENMARK) Q3 FY23 Earnings Concall Transcript
Glenmark Pharmaceuticals Limited (NSE:GLENMARK) Q3 FY23 Earnings Concall dated Feb. 13, 2023. Corporate Participants: Utkarsh Gandhi -- General Manager, Investor Relations Glenn Saldanha -- Chairman and
Alembic Pharmaceuticals LTD. (NSE: APLLTD): Q3 FY23 Results Out; Total Income Rises 18% YoY
Alembic Pharmaceuticals Ltd. (NSE:APLLTD) is an Indian pharmaceutical company that was founded in 1907. It is headquartered in Vadodara, Gujarat, and operates
Lupin Ltd Q3 FY23 Earnings Conference Call Insights
Key highlights from Lupin Ltd (LUPIN) Q3 FY23 Earnings Concall Management Update: [00:03:30] LUPIN said it is optimistic of growing its US
Ajanta Pharma Limited (NSE: AJANTAPHARMA): Q3 FY23 Results Out; Total Income Rises 17% YoY
Ajanta Pharma Limited (NSE: AJANTAPHARMA) is an Indian pharmaceutical company that specializes in the production and distribution of generic drugs. The company
Strides Pharma Science Limited (STAR) Q3 FY23 Earnings Concall Transcript
Strides Pharma Science Limited (NSE:STAR) Q3 FY23 Earnings Concall dated Jan. 24, 2023. Corporate Participants: Abhishek Singhal -- Investor Relations Arun Kumar -- Executive Chairperson &
Alkem Laboratories Ltd (ALKEM) Q3 FY23 Earnings Concall Transcript
Alkem Laboratories Ltd (NSE:ALKEM) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Tushar Manudhane -- Investor Relations Amit Kumar Khandelia -- AVP Finance Sandeep
NATCO Pharma Limited (NATCOPHARM) Q3 FY23 Earnings Concall Transcript
NATCO Pharma Limited (NSE:NATCOPHARM) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Rajesh Chebiyam -- Executive Vice President of Crop Health Science
ABBOTT INDIA LTD Ltd. (NSE: ABBOTTINDIA): Q3 FY23 Results Out; Total Income Rises 10% YoY
Abbott India Limited (NSE:ABBOTTINDIA) is a subsidiary of Abbott Laboratories, a multinational healthcare company. It was established in India in 1944 and
Alkem Laboratories Ltd. (NSE: ALKEM): Q3 FY23 Results Out; Total Income Rises 15% YoY
Alkem Laboratories Ltd.(NSE:ALKEM) is a pharmaceutical company that specializes in developing, manufacturing, and marketing of pharmaceutical and nutraceutical products. The company operates
JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) Q3 FY23 Earnings Concall Transcript
JB Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Q3 FY23 Earnings Concall dated Feb. 09, 2023. Corporate Participants: Jason D'Souza -- Vice President, Investor Relations Nikhil
Piramal Pharma Ltd (PPLPHARMA) Q3 FY23 Earnings Concall Transcript
Piramal Pharma Ltd (NSE: PPLPHARMA) Q3 FY23 Earnings Concall dated Feb. 09, 2023 Corporate Participants: Gagan Borana -- General Manager, Investor Relations and Sustainability
Earnings Summary Of Gland Pharma For Q3 FY23
Gland Pharma Limited (NSE: GLAND) is an Indian pharmaceutical company that specialises in producing high-quality, low-cost generic medications. The company has a
Gland Pharma’s Acquisition Of Cenexi & Decline In Lead Product’s Market Share
Gland Pharma Limited (NSE: GLAND) is a major player in the Indian pharmaceutical market, specialising in the production and sale of generic
Piramal Enterprises Ltd Q3 FY23 Earnings Conference Call Insights
Key highlights from Piramal Enterprises Ltd (PEL) Q3 FY23 Earnings Concall Q&A Highlights: [00:16:30] Abhijit Tibrewal from Motilal Oswal asked about asset